Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
Cost-effectiveness of fuzuloparib, with or without apatinib, for BRCA mutation HER2-negative metastatic breast cancer in China.
Fu Y et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
information security management
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Reduced susceptibility to triclosan and proposed epidemiological cut-off values for disinfectants and heavy metals in Escherichia coli isolated from Thai tilapia farms: Implications for One Health antimicrobial resistance surveillance.
#1039988
Edible coatings and films in meat preservation: Materials, functional mechanisms, and technological challenges.
#1039989
Palm Vein Biometrics A Rapid Patient Identification Tool for Emergency and Trauma Care.
#1039990
Directions for Establishing a Korean National One Health Joint Plan of Action: Focusing on Zoonotic Disease Preparedness and Response.
#1039991
Intensive arable farming calls for resilient wild bee restoration amid severe abundance fluctuations.
#1039992
Record
· ID 378576
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.